Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine. (Q39259281)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

multicenter clinical trial

0 references

0 references

0 references

irritable bowel syndrome

1 reference

based on heuristic

inferred from title

Seung-Jae Myung

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Poong-Lyul Rhee

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

author name string

K J Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

N Y Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J K Kwon

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

K C Huh

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

O Y Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

J S Lee

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

S C Choi

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

C I Sohn

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

M K Choi

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Neurogastroenterology and Motility

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1098-1104

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21920001%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Recognizing and managing patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Inhibitory effects of ramosetron, a potent and selective 5-HT3-receptor antagonist, on conditioned fear stress-induced abnormal defecation and normal defecation in rats: comparative studies with antidiarrheal and spasmolytic agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Effects of serotonin 5-HT3 receptor antagonists on stress-induced colonic hyperalgesia and diarrhoea in rats: a comparative study with opioid receptor agonists, a muscarinic receptor antagonist and a synthetic polymer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

A phase II trial of the novel serotonin type 3 receptor antagonist ramosetron in Japanese male and female patients with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Alosetron relieves pain and improves bowel function compared with mebeverine in female nonconstipated irritable bowel syndrome patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Functional bowel disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Ramosetron, a 5-HT3 receptor antagonist for the control of nausea and vomiting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01771.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39259281&oldid=1632604386"